Trial reportWorld journal of urology2005
Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy.
Trial report in World journal of urology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Antibiotic prophylaxis for transrectal prostate biopsy.The Cochrane database of systematic reviews · 2011Pooled it
- The Effect of Different Antibiotic Regimens on Bacterial Resistance: A Systematic Review.Antibiotics (Basel, Switzerland) · 2020Review
- Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis.Investigative and clinical urology · 2019Article
- Assessment of Guideline Discordance With Antimicrobial Prophylaxis Best Practices for Common Urologic Procedures.JAMA network open · 2018Article
- Comparison of guideline recommendations for antimicrobial prophylaxis in urologic procedures: variability, lack of consensus, and contradictions.International urology and nephrology · 2018Review
- Strategies for prevention of ultrasound-guided prostate biopsy infections.Infection and drug resistance · 2016Review
- Antibiotic use in urological surgeries: a six years review at Muhimbili National Hospital, Dar es salaam-Tanzania.The Pan African medical journal · 2015Article
- Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate.World journal of urology · 2014Article
- Microbiological characteristics of acute prostatitis after transrectal prostate biopsy.Korean journal of urology · 2013Article
- Does intravenous cefuroxime improve the efficacy of ciprofloxacin for preventing infectious complications after transrectal prostate biopsy? A prospective comparative study.Arab journal of urology · 2012Article
- Biopsy standards for detection of prostate cancer.World journal of urology · 2007Review
- The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy.International braz j urol : official journal of the Brazilian Society of UrologyArticle
- Oral antibiotics in trans-rectal prostate biopsy and its efficacy to reduce infectious complications: Systematic review.Urology annalsArticle
- Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases.International braz j urol : official journal of the Brazilian Society of UrologyArticle
- Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A prospective, randomized trial in which 236 patients received oral levofloxacin, either at 600 mg/day for 1 day (n = 124) or 300 mg/day for 3 days (n = 112). Urinalysis, plasma white blood cell count (WBC) (per mm3), and C reactive protein (CRP) (mg/dl) levels were checked before prostate biopsy (PBX), on the day after PBX, and on the seventh day after PBX. Two patients (1.61%) who received 600 mg for 1 day and 2 patients (1.79%) who received 300 mg for 3 days had febrile infectious complications. There was no statistically significant difference between levofloxacin at 600 mg for 1 day and levofloxacin at 300 mg for 3 days regarding the elevation of WBC and CRP. We can perform PBX safely with levofloxacin at 600 mg for 1 day as prophylaxis and recommend this method from the point of view of the decrease of antibiotic-resistant strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.